Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma.

Head and neck squamous cell carcinomas (HNSCCs) represent clinically and etiologically heterogeneous tumors affecting >40 000 patients per year in the USA. Previous research has identified individual epigenetic alterations and, in some cases, the relationship of these alterations with carcinogen exposure or patient outcomes, suggesting that specific exposures give rise to specific types of molecular alterations in HNSCCs. Here, we describe how different etiologic factors are reflected in the molecular character and clinical outcome of these tumors. In a case series of primary, incident HNSCC (n = 68), we examined the DNA methylation profile of 1413 autosomal CpG loci in 773 genes, in relation to exposures and etiologic factors. The overall pattern of epigenetic alteration could significantly distinguish tumor from normal head and neck epithelial tissues (P < 0.0001) more effectively than specific gene methylation events. Among tumors, there were significant associations between specific DNA methylation profile classes and tobacco smoking and alcohol exposures. Although there was a significant association between methylation profile and tumor stage (P < 0.01), we did not observe an association between these profiles and overall patient survival after adjustment for stage; although methylation of a number of specific loci falling in different cellular pathways was associated with overall patient survival. We found that the etiologic heterogeneity of HNSCC is reflected in specific patterns of molecular epigenetic alterations within the tumors and that the DNA methylation profiles may hold clinical promise worthy of further study.

[1]  J. Grandis,et al.  Advances in molecular diagnostics and therapeutics in head and neck cancer , 2006, Current treatment options in oncology.

[2]  R. Tibshirani,et al.  Efficient quadratic regularization for expression arrays. , 2004, Biostatistics.

[3]  B. Christensen,et al.  Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. , 2006, Cancer research.

[4]  B. Schölkopf,et al.  Sparse Multinomial Logistic Regression via Bayesian L1 Regularisation , 2007 .

[5]  J. Becker,et al.  Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. , 1985, The Journal of investigative dermatology.

[6]  D. Riesner,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003 .

[7]  Peter W. Laird,et al.  A comparison of cluster analysis methods using DNA methylation data , 2004, Bioinform..

[8]  Chun-Yang Fan,et al.  Epigenetic alterations in head and neck cancer: Prevalence, clinical significance, and implications , 2004, Current oncology reports.

[9]  D. Winn,et al.  Smoking and drinking in relation to oral and pharyngeal cancer. , 1988, Cancer research.

[10]  Wei Jiang,et al.  High-throughput DNA methylation profiling using universal bead arrays. , 2006, Genome research.

[11]  R. Kandpal,et al.  Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. , 2004, Biochemical and biophysical research communications.

[12]  T. Watts,et al.  Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium , 2007, BDJ.

[13]  Andrew W Boyd,et al.  Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival , 2006, BMC Cancer.

[14]  Adrian E. Raftery,et al.  Model-Based Clustering, Discriminant Analysis, and Density Estimation , 2002 .

[15]  K. Kelsey,et al.  Human papillomavirus 16 and head and neck squamous cell carcinoma , 2007, International journal of cancer.

[16]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[17]  Mei Liu,et al.  Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival , 2004, Oncogene.

[18]  C. Marsit,et al.  Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma , 2006, International journal of cancer.

[19]  Rebecca A Betensky,et al.  Feature‐Specific Penalized Latent Class Analysis for Genomic Data , 2006, Biometrics.

[20]  E. Andres Houseman,et al.  Global DNA Methylation Level in Whole Blood as a Biomarker in Head and Neck Squamous Cell Carcinoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[21]  Yuan Ji,et al.  Applications of beta-mixture models in bioinformatics , 2005, Bioinform..

[22]  M. Lackmann,et al.  Eph‐modulated Cell Morphology, Adhesion and Motility in Carcinogenesis , 2005, IUBMB life.

[23]  Margaret R. Karagas,et al.  Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions , 2008, BMC Bioinformatics.

[24]  M. Takagi,et al.  Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[25]  C. Marsit,et al.  Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. , 2007, Carcinogenesis.

[26]  S. Robbins,et al.  The Eph receptor/ephrin system: an emerging player in the invasion game. , 2008, Current issues in molecular biology.

[27]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[28]  Witold Zatonski,et al.  Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. , 2007, Journal of the National Cancer Institute.